If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 480.00
Ask: 490.00
Change: -2.00 (-0.41%)
Spread: 10.00 (2.083%)
Open: 487.00
High: 489.00
Low: 485.00
Prev. Close: 487.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update disposal by LEBC of Aspira

13 Nov 2023 09:42

RNS Number : 2421T
B.P. Marsh & Partners PLC
13 November 2023
 

13 November 2023

B.P. Marsh & Partners Plc

("B.P. Marsh", the "Company" or the "Group")

 

Investee Company Update - disposal by LEBC Holdings Limited of Aspira Corporate Solutions Limited

 

B.P. Marsh & Partners Plc (AIM:BPM), the specialist private equity investor in early stage financial services businesses, is pleased to announce that LEBC Holdings Limited ("LEBC") has conditionally sold Aspira Corporate Solutions Limited ("Aspira"), a wholly-owned subsidiary of LEBC, to Titan Wealth Holdings Limited ("Titan Wealth"), the discretionary fund management/wealth and asset management business (the "Transaction").

 

Background to the Investment

 

B.P. Marsh invested in LEBC in 2007, when its main operating subsidiary was LEBC Group Limited ("LEBC Group"), the national independent financial advisory ("IFA") firm. In 2017, LEBC acquired Aspira, the Bristol-based IFA founded in 2003 by its CEO, Derek Miles.

 

B.P. Marsh has a 59.34% shareholding in LEBC (the only majority position held within the current portfolio), the business of which has grown to provide pensions and investment advice to more than 1,600 corporate entities and over 15,000 individuals with circa £4 billion of assets under advice.

 

As previously announced, over the past three years LEBC has gone through a restructuring process led by Derek Miles and his management team in close consultation with the FCA. As announced by the Company on 9 August 2023, this process resulted in the consolidation of LEBC Group into Aspira, bringing the two businesses together under one brand with the intention of delivering an enhanced service for individual and corporate clients.

 

B.P. Marsh has been invested in LEBC for over 15 years and has supported the business through many changes in the advice market. The new ownership under Titan Wealth offers an exciting future for Aspira, and the Company wishes all stakeholders every success.

 

The Transaction

 

On 10 November 2023, LEBC agreed to sell 100% of Aspira to Titan Wealth, subject to regulatory approval.

 

LEBC will receive proceeds of sale over a three year earn-out period. The Group's expectation is that this will be at least in line with the Company's most recent published valuation of LEBC as at 31 July 2023, of £15,947,000. Additionally, the Group expects to receive repayment in full of its outstanding loans with LEBC, a total of £3.3m.

 

The Transaction will also allow LEBC to meet its obligations, as agreed with the FCA, regarding historical defined benefit pension transfer advice.

 

Commenting on the Transaction, Derek Miles, Chief Executive Officer of Aspira, said:

 

"I would like to thank all at B.P. Marsh for their longstanding support of LEBC and Aspira since their original investment back in 2007. Since I became CEO of the business in 2020, I have worked very closely with B.P. Marsh, who supported me fully in a comprehensive restructuring of the business, which has led to this eventual sale.

 

Such a sale has safeguarded the future of Aspira, as by combining our strengths and resources with Titan Wealth, we will be able to provide even greater value to our customers and further enhance our pensions advisory service. This would not have been possible without the full support of B.P. Marsh."

 

Oliver Bogue, Non-Executive Chairman of LEBC and B.P. Marsh Nominee Director on the Board of LEBC and Aspira, stated:

 

"It has been a pleasure to work with Derek Miles and the team at Aspira, seeing the business through this period of transformational change. This sale marks an exciting new chapter for Aspira, and is a natural next step in their progression.

 

At B.P. Marsh's current valuation, this transaction produces an Internal Rate of Return of 8.33%. This investment outlines B.P. Marsh's ability to support a business in the long term through uncertain times, safeguarding shareholder value. Such a result is also testament to Derek Miles and his team, given the fundamental changes the business has been though over the past number of years."

 

 

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon

Atholl Tweedie / Stephen Jones / Amrit Mahbubani / Ailsa MacMaster

+44 (0)20 7886 2500

Financial PR & Investor Relations

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson / Katie Hopkins

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fourteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

 

 

- Ends - 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISBJBLTMTJBMLJ
Date   Source Headline
15th Apr 201910:21 amRNSForm 8.3 - B.P Marsh & Partners PLC
4th Apr 20195:49 pmRNSDirector/PDMR Shareholding
4th Apr 20195:47 pmRNSDirector/PDMR Shareholding
4th Apr 20195:43 pmRNSDirector/PDMR Shareholding
1st Apr 20196:25 pmRNSDirector/PDMR Shareholding
1st Apr 20194:44 pmRNSInvestee Co. Update - Nexus Underwriting Mgt Ltd
20th Mar 20199:53 amRNSTransaction in Own Shares
19th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20194:41 pmRNSTransaction in Own Shares
13th Mar 20193:55 pmRNSTransaction in Own Shares
12th Mar 20192:34 pmRNSShare Buy-Back Policy Update
11th Mar 20194:54 pmRNSTransaction in Own Shares
7th Mar 20195:53 pmRNSTransaction in Own Shares
6th Mar 20195:22 pmRNSTransaction in Own Shares
5th Mar 20196:10 pmRNSDirector/PDMR Shareholding
5th Mar 20196:07 pmRNSTransaction in Own Shares
28th Feb 20195:50 pmRNSDirector/PDMR Shareholding
26th Feb 20194:51 pmRNSDirector/PDMR Shareholding
25th Feb 20196:26 pmRNSTransaction in Own Shares
21st Feb 20193:47 pmRNSTransaction in Own Shares
19th Feb 20191:09 pmRNSDirector/PDMR Shareholding
18th Feb 20194:28 pmRNSTransaction in Own Shares
8th Feb 20193:11 pmRNSDirector/PDMR Shareholding
7th Feb 20197:00 amRNSTrading Update
4th Feb 20193:45 pmRNSDirector/PDMR Shareholding
22nd Jan 20193:30 pmRNSTransaction in Own Shares
18th Jan 201911:49 amRNSInvestee Company Update - XPT Group LLC
17th Jan 20191:31 pmRNSTransaction in Own Shares
17th Jan 20191:26 pmRNSDirector/PDMR Shareholding
21st Dec 20188:22 amRNSInvestee Company Update
20th Dec 20184:39 pmRNSHolding(s) in Company
19th Dec 201812:19 pmRNSDirectorate Change
11th Dec 20185:19 pmRNSDirector/PDMR Shareholding
10th Dec 20183:46 pmRNSDirector/PDMR Shareholding
10th Dec 20183:46 pmRNSInvestee Company Update
7th Dec 20185:49 pmRNSDirector/PDMR Shareholding
6th Dec 20184:15 pmRNSTransaction in Own Shares
3rd Dec 20185:20 pmRNSTransaction in Own Shares
28th Nov 201810:53 amRNSTransaction in Own Shares
22nd Nov 20181:59 pmRNSTransaction in Own Shares
30th Oct 201811:51 amRNSInvestee Company update
29th Oct 20184:32 pmRNSDirector/PDMR Shareholding
29th Oct 201812:02 pmRNSTransaction in Own Shares
25th Oct 20186:01 pmRNSTransaction in Own Shares
23rd Oct 20186:10 pmRNSTransaction in Own Shares
18th Oct 20184:59 pmRNSDirector/PDMR Shareholding
16th Oct 20185:58 pmRNSDirector/PDMR Shareholding
16th Oct 20187:00 amRNSInterim Results
11th Oct 20187:00 amRNSShare Buy-Back Policy
12th Sep 20181:04 pmRNSInvestee Company Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.